EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19

Bernhard Kratzer iD, Pia Gattinger iD, Doris Trapin, Paul Ettel, Ulrike Körmöczi, Arno Rottal, Robert B Stieger iD, Al Nasar Ahmed Sehgal iD, Melanie Feichter, Kristina Borochova, Inna Tulaeva iD, Katharina Grabmeier-Pfistershammer iD und 8 weitere

Allergy · 2024-09 · 79 (9) · 2482-2501

DOI: 10.1111/all.16210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 14.07.2024. Verfasst von Bernhard Kratzer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Cytokines, Antibodies, Viral. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

SARS‐CoV‐2 has triggered a pandemic and contributes to long‐lasting morbidity. Several studies have investigated immediate cellular and humoral immune responses during acute infection. However, little is known about long‐term effects of COVID‐19 on the immune system.

Methods

We performed a longitudinal investigation of cellular and humoral immune parameters in 106 non‐vaccinated subjects ten weeks (10 w) and ten months (10 m) after their first SARS‐CoV‐2 infection. Peripheral blood immune cells were analyzed by multiparametric flow cytometry, serum cytokines were examined by multiplex technology. Antibodies specific for the Spike protein (S), the receptor‐binding domain (RBD) and the nucleocapsid protein (NC) were determined. All parameters measured 10 w and 10 m after infection were compared with those of a matched, noninfected control group ( n = 98).

Results

Whole blood flow cytometric analyses revealed that 10 m after COVID‐19, convalescent patients compared to controls had reduced absolute granulocyte, monocyte, and lymphocyte counts, involving T, B, and NK cells, in particular CD3 + CD45RA + CD62L + CD31 + recent thymic emigrant T cells and non‐class‐switched CD19 + IgD + CD27 + memory B cells. Cellular changes were associated with a reversal from Th1‐ to Th2‐dominated serum cytokine patterns. Strong declines of NC‐ and S‐specific antibody levels were associated with younger age (by 10.3 years, p < .01) and fewer CD3 − CD56 + NK and CD19 + CD27 + B memory cells. Changes of T‐cell subsets at 10 m such as normalization of effector and Treg numbers, decline of RTE, and increase of central memory T cell numbers were independent of antibody decline pattern.

Conclusions

COVID‐19 causes long‐term reduction of innate and adaptive immune cells which is associated with a Th2 serum cytokine profile. This may provide an immunological mechanism for long‐term sequelae after COVID‐19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2CytokinesAntibodies, ViralTh2 CellsAdaptive ImmunityImmunity, InnateTh1 CellsHumansMaleFemaleMiddle AgedAdultAgedSpike Glycoprotein, CoronavirusLongitudinal StudiesCoronavirus Nucleocapsid Proteins

Stichwörter der Autor:innen

CD19+CD27+ B memory cellsCOVID‐19SARS‐CoV‐2Th1/Th2 cytokine shiftleukopenialong‐term effectrecent thymic emigrantsspecific antibody decline

Substanzen

CytokinesAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Coronavirus Nucleocapsid Proteins

Autor:innen und Institutionen

  • Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Medical University of Vienna, Vienna, Austria.
  • Center for Pathophysiology, Infectiology and Immunology, Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
  • Laboratory for Immunopathology, Department of Clinical Immunology and Allergology, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna, Austria.
  • Center for Public Health, Department for Environmental Health, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Bernhard Kratzer, Pia Gattinger, Robert B Stieger, Al Nasar Ahmed Sehgal, Inna Tulaeva, Katharina Grabmeier-Pfistershammer, Peter A Tauber, Thomas Perkmann, Ingrid Fae, Sabine Wenda, Michael Kundi, Gottfried F Fischer, Rudolf Valenta, Winfried F Pickl

Zitieren

APA

Kratzer, B., Gattinger, P., Trapin, D., Ettel, P., Körmöczi, U., Rottal, A., Stieger, R. B., Sehgal, A. N. A., Feichter, M., Borochova, K., Tulaeva, I., Grabmeier-Pfistershammer, K., Tauber, P. A., Perkmann, T., Fae, I., Wenda, S., Kundi, M., Fischer, G. F., Valenta, R., & Pickl, W. F. (2024). Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19. Allergy, 79(9), 2482-2501. https://doi.org/10.1111/all.16210

Vancouver

Kratzer B, Gattinger P, Trapin D, Ettel P, Körmöczi U, Rottal A, et al. Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19. Allergy. 2024;79(9):2482-2501. doi:10.1111/all.16210

BibTeX
@article{Kratzer2024,
  author = {Kratzer, Bernhard and Gattinger, Pia and Trapin, Doris and Ettel, Paul and Körmöczi, Ulrike and Rottal, Arno and Stieger, Robert B and Sehgal, Al Nasar Ahmed and Feichter, Melanie and Borochova, Kristina and Tulaeva, Inna and Grabmeier-Pfistershammer, Katharina and Tauber, Peter A and Perkmann, Thomas and Fae, Ingrid and Wenda, Sabine and Kundi, Michael and Fischer, Gottfried F and Valenta, Rudolf and Pickl, Winfried F},
  title = {Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19},
  journal = {Allergy},
  year = {2024},
  volume = {79},
  number = {9},
  pages = {2482--2501},
  doi = {10.1111/all.16210}
}
Kostenlos starten →